BN

Biju Kapplingattu Krishnan Namboodiri - Profile

Biju Kapplingattu Krishnan Namboodiri, Director and Whole-Time Director, with 6 companies.

About Biju Kapplingattu Krishnan Namboodiri

Biju Kapplingattu Krishnan Namboodiri has 17 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 2 companies, including Albus Pharmaceuticals Private Limited and Fling Pharmaceuticals Private Limited. Formerly with 4 companies, such as Wellness Diet Private Limited and Ave Health Care Private Limited. Engaged in General Business, Healthcare.

Current Companies 2
Past Companies 4
Total Affiliations 6
Oldest Company Age 22
Companies Associated with Biju Kapplingattu Krishnan Namboodiri
Current Companies
Previous Companies

Explore Director's current and past company associations— Uncover their professional journey today!

Frequently Asked Questions
Who is Biju Kapplingattu Krishnan Namboodiri?

Biju Kapplingattu Krishnan Namboodiri has 17 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 2 companies, including Albus Pharmaceuticals Private Limited and Fling Pharmaceuticals Private Limited. Formerly with 4 companies, such as Wellness Diet Private Limited and Ave Health Care Private Limited. Engaged in General Business, Healthcare.

What is Biju Kapplingattu Krishnan Namboodiri's role in current companies?

Biju Kapplingattu Krishnan Namboodiri is associated with 2 companies as Director and Whole-Time Director.

What industries does Biju Kapplingattu Krishnan Namboodiri specialize in?

Biju Kapplingattu Krishnan Namboodiri has expertise in General Business, Healthcare.

How many years of experience does Biju Kapplingattu Krishnan Namboodiri have?

Biju Kapplingattu Krishnan Namboodiri has 17 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available